Trovagene this week said that Paul Billings has joined the company's scientific advisory board.
Billings is a board-certified internist and clinical geneticist, and currently serves as CMO at Life Technologies. He has authored nearly 200 publications and books on genomic medicine and currently serves on the SAB of the US Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the National Academy of Sciences Institute of Medicine's Roundtable on Genomics. Prior to joining Life Tech, he served as director and CSO of the Genomic Medicine Institute at El Camino Hospital. Previously, he was senior vice president for corporate development at LabCorp. Billings has founded or served as CEO of a number of genetic and diagnostic medicine companies, including GeneSage, Omicia, and Cellective Dx.
Billings has also held academic appointments at Harvard Medical School, Stanford School of Medicine, and the University of California, Berkeley, and has served as a physician at a number of medical centers throughout the country, including the University of California, San Francisco. Billings holds an MD from Harvard Medical School and a PhD in immunology from Harvard University.